BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2230926, ERBB2, Apoptosis, Arthritis, Breast, Human chorionic gonadotropin, Bleomycin)
Bookmark Forward

QuickView for regulation of phosphatidylinositol 3-kinase activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Lung
  2. Pituitary gland
  3. Adipose tissue
  4. Uterus
  5. Pharyngeal mucosa
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alpha-1-antitrypsin deficiency
  2. Disorder of digestive system
  3. Disease due to Orthopoxvirus
  4. Legionella infection
  5. Contact dermatitis
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. KW 2449
  2. FR 180204
  3. ARQ 197
  4. dinaciclib
  5. COOH-terminal signal transamidase
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. FGFR1
  2. TBC1D23
  3. SETD1A
  4. CAMK1
  5. NR5A1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Melanoma A375 cells with CRISPR-targeted gene knockouts
  2. Adipose tissue, adipocytes and stromal-vascular pellet cells from multiple body regions
  3. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
  4. L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
  5. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Phosphoinositide (PI) 3-kinase assays.
  2. Regulation of retinal phosphoinositide 3-kinase activity in p85alpha-subunit knockout mice.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Polyphenol-rich Dark Chocolate on Obesity
  2. Replacement of Vitamin D in Patients With Active Tuberculosis
  3. Everolimus for Children With Recurrent or Progressive Ependymoma
  4. A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.
  5. BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.